340B Hospitals’ Share of Part B Drug Administration Continues Rising, PhRMA-Funded Study Finds

Image of Infusion drip
New drug industry-funded research found that Part B drug administration continues rising at 340B hospitals and falling at other hospitals and physician offices.

Thirty-five percent of drugs paid for by Medicare Part B in 2021 were administered in 340B hospital outpatient departments, up from 19% in 2012, new research funded by brand drug manufacturers shows.

The share of Part B drugs administered in

Read More »

U.S. Retail Drug Spending Rose 7.8% in 2021, as COVID Eased and Patients Got Care They Postponed

Image of miniature shopping cart and medicine blister packs
Retail prescription drug spending rose by 7.8% in 2021, as COVID-19 eased and patients got care they had been putting off, CMS says.

Retail prescription drug spending in the U.S. shot up 7.8% to $378 billion in 2021, more than double the 3.7% spending growth rate in 2020, as the easing of the COVID-19 pandemic brought a surge in doctor visits and a

Read More »

340B Report Analysis: Federal 340B Law Gives States Room to Regulate their Own Drug Distribution Systems, Judge Rules in Arkansas Contract Pharmacy Case

U.S. District Court Little Rock, AR court room
A federal judge in Little Rock, Ark., held that the state's novel 340B anti-discrimination law is not preempted by federal laws.

As we reported on deadline on Tuesday, a federal district court ruled this week that Arkansas’ novel 340B antidiscrimination law is not preempted by federal laws governing the 340B program, a decision that strikes down one of two legal arguments

Read More »

117th Congress Nears End With No 340B Contract Pharmacy Fix Expected

U.S. Capitol building at sunrise
Congress is on track to end its current session next week without addressing drug manufacturers’ denials of 340B pricing when covered entities contract with outside pharmacies.

The 117th Congress appears destined to end without further action on the 340B program.

The House and Senate are on track to finish all work for the year by no later than Friday, Dec. 23. According to news reports yesterday,

Read More »

The Time to Step Up Is Now: Advocating for 340B

silhouettes of colorful hands


Pop Quiz: Which of these statements are false?

  1. The United States spends more on health care than any other developed nation. But when compared to 11 other high-income countries, the U.S. ranks last for access to care, health equity, and health outcomes. Case in point: Despite significant advances in HIV prevention and treatment in the
Read More »

340B Registration for First Quarter of 2023 Will Run from Jan. 1 to Jan. 17

Image of pen and clipboard with medical cross symbol
The first quarter 2023 registration period for covered entity enrollment in 340B will begin Jan. 1 and end Jan. 17.

The U.S. Health Resources and Services Administration has slightly adjusted the dates of the first of four periods in 2023 during which eligible entities may register themselves, their child sites, and their contract pharmacies to participate in the 340B program.

Read More »

Breaking: Biogen Announces 340B Contract Pharmacy Restrictions

Biogen wordmark on building facade
Biogen is the 19th prescription drug company to announce conditions on 340B pricing when covered entities contract with outside pharmacies.

Biopharmaceutical manufacturer Biogen yesterday became the 19th prescription drug company to announce conditions on 340B pricing when covered entities contract with outside pharmacies.

Massachusetts-based Biogen posted a Dec. 12 letter to entities and an accompanying FAQ describing its new

Read More »

Breaking: Federal Law Doesn’t Preempt Arkansas’s Novel 340B Contract Pharmacy Law, Judge Rules

Arkansas Insurance Department office sign
The Arkansas Insurance Department is enforcing a state 340B contract pharmacy law amid an ongoing legal challenge from PhRMA.

A federal district judge ruled yesterday that Arkansas’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the U.S. Food and Drug Administration’s Risk Evaluation and Mitigation Strategies requirements.

U.S. Senior District Judge Billy Roy Wilson’s

Read More »

Michigan Senate Rejects Attempt to Weaken Recent 340B Anti-Discrimination Law

Michigan Senate chamber
The Michigan Senate defeated legislation that hospitals say would have weakened a new state law that protects 340B contract pharmacy arrangements.

The Michigan Senate has defeated legislation that hospitals say would have removed language from a nearly year-old state law that stops payers, pharmacy benefit managers, or other third parties from requiring 340B claims modifiers except as required to prevent Medicaid

Read More »

340B’s Critics Often Misunderstand its Intent, Ex-House E&C Chair Waxman Says in Health Affairs Commentary

Henry Waxman headshot
Ex-U.S. Rep. Henry Waxman (D-Calif.) says in a Health Affairs commentary that criticism of the drug discount program often “reflect[s] a misunderstanding of Congress’ intent.”

Henry Waxman, a California Democrat who was one of the original sponsors of the 340B law when it was created in 1992, says in a commentary in Health Affairs that criticism of the drug discount program often “reflect[s] a misunderstanding

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report

Site Footer